Ferring Pharmaceuticals Inc

Ferring Pharmaceuticals Inc., part of the Ferring Group, a privately owned, international pharmaceutical company, markets Menopur® (menotropins for injection, USP), Bravelle® (urofollitropin for injection, purified), Repronex® (menotropins for injection, USP) and Novarel® (chorionic gonadotropin for injection, USP) in the U.S. to infertility specialists and their patients. Ferring also offers the Q,CAP, the first and only needle-free reconstitution device, for use with its fertility treatments. The Ferring Group specializes in the research, development and commercialization of compounds in general and pediatric endocrinology, urology, gastroenterology, obstetrics/gynecology and infertility. ( www.ferring.com )